We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
In January 2012, GlaxoSmithKline (GSK) announced an interruption to the supply of Typherix® (Vi polysaccharide typhoid vaccine) and Hepatyrix® (hepatitis A and typhoid combined).
This is an update on the availability of hepatitis A and typhoid vaccines.
Currently:
Typherix® - is now out of stock until the second quarter at the earliest, 2014.
Hepatyrix® - limited supplies will be available towards the end of 2012. Once this stock is depleted, the vaccine will be out of stock until the second quarter 2014.
Havrix Monodose® and Havrix Junior Monodose® - there are currently no supply constraints on these products.
Enquiries to: GSK Customer Contact Team, Tel: 0808 100 9997
Ongoing Vaccine Supplies
Typhim Vi® (Vi polysaccharide typhoid vaccine) - Sanofi Pasteur MSD is experiencing a supply problem with the typhoid vaccine, Typhim Vi®. As such, they are unable to distribute further supplies at this time.
Avaxim® (hepatitis A vaccine) - Sanofi Pasteur MSD, currently there are no supply constraints on this product and customers are being supplied as normal.
ViATIM® (hepatitis A/typhoid vaccine) - Sanofi Pasteur MSD, currently there are supply constraints on this product.
Vaqta Paediatric® (hepatitis A vaccine) - Sanofi Pasteur MSD, currently there are no constraints on supply of this product.
Enquiries to: Sanofi Pasteur MSD Customer Operations team, Tel: 0800 085 5511.
Vivotif® (oral typhoid vaccine) - Janssen (Crucell (UK) Ltd) due to the high demand for this product, Vivotif® is currently out of stock. New stock of vaccine is expected to be available early December 2012.
Epaxal® (hepatitis A vaccine) - Janssen (Crucell (UK) Ltd) currently there are no supply constraints on this product.
Enquiries to: Janssen, Customer services Tel:0844 800 3907
